iBankCoin
18 years in Wall Street, left after finding out it was all horseshit. Founder/ Master and Commander: iBankCoin, finance news and commentary from the future.
Joined Nov 10, 2007
23,445 Blog Posts

SPECULATION IS BACK

It’s still a bit jerky out there, with only 40% of stocks higher today. But of that 40%, there was a wide array of winners, indicative of speculation.

Spec

 

This is good news for the markets. If you were injured during the recent downtick in homosexual stocks, like FEYE and SPLK, clear your heads and get with the program. There is money in these here hills. You just need the balls to go look for it.

For the day, I made back another 0.5%.

If you enjoy the content at iBankCoin, please follow us on Twitter

11 comments

  1. The Zombie

    The Fly is God.

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  2. Carolina

    I am over in Pelican ,% change is hybrid score, right?

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  3. matt_bear

    i feel 10 feet tall and strong like an ox.

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  4. zusch

    lol I knew you’d post a danny mcbride pic today

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  5. Fagayness PenisBottom
    Fagayness PenisBottom

    Half that list is fucking midget stocks under $5, can you post a list with only big daddy names, stocks with volume and girth? Thanks

    • 0
    • 0
    • 0 Deem this to be "Fake News"
    • Cascadian

      Do a little further research on your own. Or buy index funds.

      • 0
      • 0
      • 0 Deem this to be "Fake News"
  6. TJWP

    The most interesting part of this market is how the defensive stocks (transports, utilities… etc) are all so extended already that if we do go, where is the safety?

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  7. bonobo smores

    A sad day for old man apes.

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  8. JTU

    SGEN-FYI Don’t know if you already saw this, “Today, we learned Merck is paying $24.50 a share for Idenix, a 238 percent premium to where the stock went out yesterday,” Cramer said. Therefore, Cramer thinks other smaller biotech stocks may warrant higher valuations. “Because of their robust pipelines, I think Seattle Genetics and Isis might both be worth a heck of a lot more than I thought, based on what Merck just paid for Idenix.”

    • 0
    • 0
    • 0 Deem this to be "Fake News"